Want to see BMY full AI Analyst Report?
Bristol-Myers Squibb (BMY) Income Statement
Bristol-Myers Squibb Income Statement
Last quarter (Q3 2026), Bristol-Myers Squibb's total revenue was $13.07B, an increase of 6.93% from the same quarter last year. In Q3, Bristol-Myers Squibb's net income was $2.16B. See Bristol-Myers Squibb’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 48.20B | $ 48.30B | $ 45.01B | $ 46.16B | $ 46.38B | |
| $ 34.26B | $ 34.33B | $ 34.31B | $ 36.02B | $ 36.45B | |
| $ 20.54B | $ 28.45B | $ 26.12B | $ 26.92B | $ 27.91B | |
| Depreciation and Amortization | $ 4.01B | $ 9.60B | $ 9.76B | $ 10.28B | $ 10.69B |
| $ 15.23B | $ 3.17B | $ 19.37B | $ 19.22B | $ 20.12B | |
| $ 13.72B | $ 5.89B | $ 8.20B | $ 9.10B | $ 8.54B | |
| $ -4.40B | $ -14.27B | $ 245.00M | $ -1.39B | $ -439.00M | |
| $ 9.33B | $ -8.38B | $ 8.44B | $ 7.71B | $ 8.10B | |
| $ 7.05B | $ -8.95B | $ 8.03B | $ 6.33B | $ 6.99B | |
| Per Share Metrics | |||||
| Basic EPS | $ 3.46 | $ -4.41 | $ 3.88 | $ 2.97 | $ 3.15 |
| Diluted EPS | $ 3.45 | $ -4.41 | $ 3.86 | $ 2.95 | $ 3.12 |
| Weighted Average Shares Outstanding | 2.04B | 2.03B | 2.07B | 2.13B | 2.22B |
| Weighted Average Shares Outstanding (Diluted) | 2.04B | 2.03B | 2.08B | 2.15B | 2.25B |
Currency in USD